Interventional Cardiology Devices | Market Insights | Europe (Supplemental) | 2022
The mature European IC device market will be limited by declining ASPs due to a number of factors, including intense price competition. Moreover, the COVID-19 pandemic will have a negative impact on procedure volumes and market growth in 2020. However, an increasing prevalence of complex lesions and the emergence of specialized premium-priced technologies to diagnose and treat these complex CADs will mitigate these declines to some extent.
This Medtech 360 Report provides high-level market metrics for IC devices in Europe, including country-level data for major countries and aggregate data for the rest of Europe, across a 11-year period.
